Skip to main content
PLOS One logoLink to PLOS One
. 2014 May 27;9(5):e99274. doi: 10.1371/journal.pone.0099274

Correction: Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease

The PLOS ONE Staff
PMCID: PMC4035346

Notice of Republication

This article was republished on May 9th, 2014, due to several Supporting Information files being erroneously removed. The publisher apologizes for this error. Please view this article again for all Supporting Information files. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting Information

File S1

Originally published, uncorrected article.

(PDF)

File S2

Republished, corrected article.

(PDF)

Reference

  • 1. Tóth G, Gardai SJ, Zago W, Bertoncini CW, Cremades N, et al. (2014) Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease. PLoS ONE 9(2): e87133 doi:10.1371/journal.pone.0087133 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

File S1

Originally published, uncorrected article.

(PDF)

File S2

Republished, corrected article.

(PDF)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES